ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 735037 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 735037; 2) Community: the network communities that were significantly associated with the response to NSC 735037; 3) Molecule: the relationships between components within communities and NSC 735037; 4) MDR: the compounds that were significantly associated with the NSC 735037.

NSC Compound Enrichment Correlation
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 1.18259685778447e-005 0.75256134
NSC 606869 Clofarabine 1.67336950769016e-005 0.52331561
NSC 670656 4a,14a-Epoxy-4,14-[3]hexene[1,5]diynonaphtho[2,3-c] phenanthridine-3,7,12(4H)-trione, 1,2,13,14-tetrahydro-4,6-dihydroxy-1-methyl-, stereoisomer 1.79658531880943e-005 0.79743637
NSC 618939 Camptothecin Derivative 2.27497142702985e-006 0.87006008
NSC 726332 6-[3-((2,2-Dimethoxyethylamino)-1-propyl)]-5,6-dihydro-2,3- dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c] isoquinoline 2.27718602463644e-005 0.6266568
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 6.95083784546613e-005 0.7123696
NSC 606985 Camptothecin Derivative 6.95083784546613e-005 0.76544711
NSC 616348 Irinotecan hydrochloride 6.95083784546613e-005 0.81925711
NSC 724994 2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid 6.95083784546613e-005 0.75434309
NSC 725775 6-[(3-Thiazolylamino)-1-propyl]-5,6-dihydro-2,3-dimethoxy-~ 8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 6.95083784546613e-005 0.69080098
Total:91  Current:90    [First] [Prev] [Next] [Last]